Morgan Stanley 8th Australia Summit
Neuren Pharmaceuticals is attending the Morgan Stanley 8th Australia Summit on 10 – 11 June 2026 in Sydney, Australia.
As well as conducting meetings with institutional investors, Neuren CEO Jon Pilcher will participate in a panel entitled “Australia Biotech Innovation Going Global”, along with Mesoblast CEO Silviu Itescu and Sean Laaman, Head of US SMID Cap Biotech Equity Research, Morgan Stanley, moderated by Rowan Bailey Co-Head of Healthcare, Consumer and Industrials Investment Banking, Morgan Stanley Australia.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals a question about this update.